Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Neighbourly Pharmacy Inc T.NBLY

Neighbourly Pharmacy Inc. is a Canada-based company that operates a network of community pharmacies. The Company is an owner and operator of retail pharmacies located throughout Canada under banners such as IDA/Guardian, Pharmachoice, Pharmasave and Remedy’s RX. The Company, through its subsidiaries, owns and operates a network of retail pharmacies known as Rubicon Pharmacies (Rubicon or... see more

TSX:NBLY - Post Discussion

Neighbourly Pharmacy Inc > Two Raised Targets
View:
Post by retiredcf on Oct 26, 2022 12:53pm

Two Raised Targets

This was later added to the National Bank article. GLTA

Elsewhere, others making changes include:

* Scotia Capital’s George Doumet to $27 from $25 with a “sector outperform” rating.

“We believe organic margins have troughed and expect more gradual improvement over the near to medium term (which we believe will also be supportive of the current recovery in the company’s trading multiple). Furthermore, we continue to like NBLY’s defensive characteristics and see substantial FCF generation over the NTM [next 12 months] – allowing it to attain (at least) the lower end of its 35-40 acquisition cadence, in a leverage-neutral manner,” said Mr. Doumet.

* BMO’s Peter Sklar to $25 from $20 with a “market perform” rating.

“Following a disappointing FQ1/23, Neighbourly reported a more positive FQ2/23 with stronger same-store-sales and improved margin, reflecting operating leverage over its corporate costs (a previous issue). Given this improvement, the stock rebounded sharply [on Tuesday] ... However, the stock has declined from $40 to the $20-level this year, and today’s $2+ bounce, although large in terms of percentage return, should be seen in the overall context of that decline. [Tuesday’s] quarterly result was essentially in line, we consider Neighbourly to be appropriately valued,” he said.

Comment by canasol47 on Oct 26, 2022 1:11pm
This post has been removed in accordance with Community Policy